Boye, K., Nesland, J. M., Sandstad, B., Haugland Haugen, M., Mælandsmo, G. M., & Flatmark, K. (2012). EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer. Nature Publishing Group.

Boye, K., J M. Nesland, B. Sandstad, M. Haugland Haugen, G M. Mælandsmo, and K. Flatmark. EMMPRIN Is Associated With S100A4 and Predicts Patient Outcome in Colorectal Cancer. Nature Publishing Group, 2012.

Boye, K., et al. EMMPRIN Is Associated With S100A4 and Predicts Patient Outcome in Colorectal Cancer. Nature Publishing Group, 2012.